BioNTech SE (BNTX)
USD 104.94
(2.45%)
USD 104.94
(2.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.21 Billion EUR | -74.81% |
| 2022 | 12.77 Billion EUR | -15.46% |
| 2021 | 15.11 Billion EUR | 6907.87% |
| 2020 | -222.03 Million EUR | -64.18% |
| 2019 | -135.23 Million EUR | -363.86% |
| 2018 | -29.15 Million EUR | 12.23% |
| 2017 | -33.21 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 69.24 Million EUR | -46.38% |
| 2024 Q1 | 128.5 Million EUR | -90.11% |
| 2023 Q4 | 1.29 Billion EUR | 451.74% |
| 2023 FY | 3.21 Billion EUR | -74.81% |
| 2023 Q3 | 235.6 Million EUR | 163.92% |
| 2023 Q2 | -368.6 Million EUR | -143.52% |
| 2023 Q1 | 847 Million EUR | -76.37% |
| 2022 FY | 12.77 Billion EUR | -15.46% |
| 2022 Q3 | 2.36 Billion EUR | 16.45% |
| 2022 Q2 | 2.03 Billion EUR | -57.61% |
| 2022 Q1 | 4.79 Billion EUR | 2.5% |
| 2022 Q4 | 3.58 Billion EUR | 51.48% |
| 2021 Q2 | 4.22 Billion EUR | 132.67% |
| 2021 FY | 15.11 Billion EUR | 6907.87% |
| 2021 Q1 | 1.81 Billion EUR | 3726.44% |
| 2021 Q4 | 4.67 Billion EUR | 1.35% |
| 2021 Q3 | 4.61 Billion EUR | 9.28% |
| 2020 FY | -222.03 Million EUR | -64.18% |
| 2020 Q4 | 47.44 Million EUR | 128.39% |
| 2020 Q3 | -167.08 Million EUR | -182.77% |
| 2020 Q1 | -43.3 Million EUR | -3.41% |
| 2020 Q2 | -59.08 Million EUR | -36.46% |
| 2019 Q3 | -25.96 Million EUR | 21.57% |
| 2019 Q2 | -33.1 Million EUR | 3.46% |
| 2019 Q1 | -34.29 Million EUR | -556.74% |
| 2019 FY | -135.23 Million EUR | -363.86% |
| 2019 Q4 | -41.87 Million EUR | -61.28% |
| 2018 Q1 | 18.48 Million EUR | 0.0% |
| 2018 Q4 | 7.5 Million EUR | 149.49% |
| 2018 FY | -29.15 Million EUR | 12.23% |
| 2018 Q3 | -15.17 Million EUR | -182.1% |
| 2018 Q2 | 18.48 Million EUR | 0.0% |
| 2017 FY | -33.21 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 7792.418% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -3298.541% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -112.084% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 6344601.38% |
| Apollomics, Inc. | 127 Thousand USD | -2534703.15% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 3046421.268% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 13996621.739% |
| Bicycle Therapeutics plc | -129.52 Million USD | 2585.485% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -401296.509% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -2682566.667% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -15954.259% |
| Chimerix, Inc. | 324 Thousand USD | -993480.247% |
| CRISPR Therapeutics AG | 240.95 Million USD | -1236.012% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -6363.608% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -7678.476% |
| Fortress Biotech, Inc. | 57.85 Million USD | -5464.448% |
| Fortress Biotech, Inc. | 57.85 Million USD | -5464.448% |
| Gritstone bio, Inc. | -6.26 Million USD | 51524.92% |
| Allakos Inc. | -6.14 Million USD | 52521.43% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 336484.535% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -21660.173% |
| Cytokinetics, Incorporated | -322.59 Million USD | 1097.914% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1839642.857% |
| Innoviva, Inc. | 261.06 Million USD | -1133.103% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 28218893.829% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 90756.153% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 32028753.865% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 365502.951% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 806917.043% |
| ImmuCell Corporation | 4.39 Million USD | -73125.479% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 3133.461% |
| Incyte Corporation | 3.44 Billion USD | 6.436% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 120600.328% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1653247.577% |
| Mustang Bio, Inc. | -2.22 Million USD | 144783.146% |
| MiMedx Group, Inc. | 266.84 Million USD | -1106.402% |
| MEI Pharma, Inc. | 49.32 Million USD | -6426.243% |
| MacroGenics, Inc. | 50.52 Million USD | -6271.247% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -43250.391% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 45404.754% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -10979.676% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -2196.116% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 10390649.351% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 3318862.887% |
| NextCure, Inc. | -3.68 Million USD | 87483.279% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -124966.045% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -16804.899% |
| Onconetix, Inc. | -1.12 Million USD | 285701.487% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 11212.952% |
| Opthea Limited | 21.72 Thousand USD | -14821262.799% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 267280.134% |
| Psyence Biomedical Ltd. | -240.00 USD | 1341333433.333% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 5615701.996% |
| Precigen, Inc. | 106 Thousand USD | -3036881.132% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -318948.563% |
| Prime Medicine, Inc. | -147.9 Million USD | 2276.532% |
| PureTech Health plc | -1.6 Million USD | 200923.456% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 45453.621% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 71.515% |
| Replimune Group, Inc. | -2.65 Million USD | 121350.471% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 12851710.843% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -2832.624% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 623075.311% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 905.477% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -7948.0% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 7202.482% |
| Solid Biosciences Inc. | -76.56 Million USD | 4304.642% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 26826766.667% |
| SciSparc Ltd. | 2.19 Million USD | -146493.807% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 12159.639% |
| TG Therapeutics, Inc. | 219.1 Million USD | -1369.23% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -106249.521% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 186288.548% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -2306.195% |
| UroGen Pharma Ltd. | 73.35 Million USD | -4288.701% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -73431.293% |
| XOMA Corporation | 3.86 Million USD | -83277.363% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 231863.859% |
| AbCellera Biologics Inc. | 38.02 Million USD | -8366.009% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 64384100.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 3699.969% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 10428.655% |
| Precision BioSciences, Inc. | 40.47 Million USD | -7854.141% |
| Dyadic International, Inc. | 922.95 Thousand USD | -348691.981% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 2190031.973% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -15185.124% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -759145.283% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 37157.672% |
| IGM Biosciences, Inc. | -211.66 Million USD | 1620.93% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 161382.565% |
| Acelyrin, Inc. | -115 Thousand USD | 2799404.348% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -132105.339% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -2588.2% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 24199.69% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1979.707% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 3377.64% |
| Senti Biosciences, Inc. | -2.68 Million USD | 120085.091% |
| Mesoblast Limited | -9.81 Million USD | 32898.777% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 3013.593% |
| ChromaDex Corporation | 50.78 Million USD | -6239.504% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -2572.112% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -45711.869% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -2279.851% |
| Novavax, Inc. | 639.93 Million USD | -403.05% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 3379.443% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 7506.76% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -2476207.692% |
| Celcuity Inc. | -142.77 Thousand USD | 2254883.851% |
| ContextLogic Inc. | 59 Million USD | -5356.271% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -624987.379% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -19319.678% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 5.279% |
| Amarin Corporation plc | 165.54 Million USD | -1844.654% |
| AnaptysBio, Inc. | 14.78 Million USD | -21679.311% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 567860.141% |
| Aptorum Group Limited | -1.11 Million USD | 288898.301% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -13065.924% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -1237.238% |
| Ardelyx, Inc. | 106.66 Million USD | -2918.16% |
| Celularity Inc. | 6.75 Million USD | -47556.551% |
| Omeros Corporation | -69.77 Million USD | 4713.422% |
| Humacyte, Inc. | -76.55 Million USD | 4305.356% |
| Immunocore Holdings plc | 248.39 Million USD | -1196.021% |
| IO Biotech, Inc. | -756 Thousand USD | 425920.106% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 225850.351% |
| Summit Therapeutics Inc. | -2.05 Million USD | 157134.146% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 67194.623% |
| Pulmatrix, Inc. | -8.22 Million USD | 39263.017% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 907.234% |
| Evogene Ltd. | 1.39 Million USD | -230007.219% |
| CorMedix Inc. | -205.56 Thousand USD | 1566148.2% |
| BioLineRx Ltd. | 1.1 Million USD | -290441.516% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -648932.258% |
| Sagimet Biosciences Inc. | 2 Million USD | -160860.0% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -269.032% |
| scPharmaceuticals Inc. | 9.78 Million USD | -32809.425% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 4765.778% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -576.453% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 28218893.829% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 11100789.655% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1703380.423% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -79366.798% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 613280.952% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 7285335.811% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 30920.615% |
| Daré Bioscience, Inc. | 2.76 Million USD | -116136.665% |
| bluebird bio, Inc. | -4.03 Million USD | 79980.893% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -69.043% |
| DBV Technologies S.A. | 15.72 Million USD | -20367.955% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1874.563% |
| Galecto, Inc. | -830 Thousand USD | 387955.422% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 563882.837% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 8282.396% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -528504.269% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 2246560.248% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -5793.92% |
| ADMA Biologics, Inc. | 88.21 Million USD | -3549.142% |
| Clene Inc. | 533 Thousand USD | -603877.486% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -161831.59% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 678476.129% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 30953946.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -3308056.324% |
| Century Therapeutics, Inc. | -10.8 Million USD | 29882.589% |
| Kura Oncology, Inc. | -849 Thousand USD | 379275.501% |
| Surrozen, Inc. | -27.23 Million USD | 11922.255% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 4897.33% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -3150.437% |
| Autolus Therapeutics plc | -4.86 Million USD | 66243.415% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1916290.476% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 4248.561% |
| GRI Bio, Inc. | 10.84 Million USD | -29594.678% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -126640.856% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 6972.905% |
| INmune Bio, Inc. | 155 Thousand USD | -2076803.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -5097.372% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 213817.004% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 496542.307% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 42525859.577% |
| Jaguar Health, Inc. | 7.72 Million USD | -41577.887% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 10996888.959% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -800696.02% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -40799.505% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 1028598.403% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -3307.967% |
| Verastem, Inc. | -62 Thousand USD | 5192358.065% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 1233509.962% |
| Histogen Inc. | 3.76 Million USD | -85312.576% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -558615.26% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -372.921% |
| Surrozen, Inc. | -27.23 Million USD | 11922.255% |
| Organovo Holdings, Inc. | -5.38 Million USD | 59836.5% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 162585958.586% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -52965.868% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 4795500.039% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -2207856.104% |
| Kronos Bio, Inc. | 1.37 Million USD | -234535.569% |
| Turnstone Biologics Corp. | 16.5 Million USD | -19403.211% |
| Synaptogenix, Inc. | -6347.00 USD | 50720125.209% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 6312256.863% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -10951.529% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -1894.98% |
| Exelixis, Inc. | 1.75 Billion USD | -83.152% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 2970.16% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -852.198% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 290641.516% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 2716930.814% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -43890.155% |
| Insmed Incorporated | 239.63 Million USD | -1243.376% |
| MediWound Ltd. | 3.57 Million USD | -89872.051% |
| OmniAb, Inc. | 14.66 Million USD | -21848.592% |
| Alector, Inc. | -95.05 Million USD | 3486.742% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -2462.629% |
| Zai Lab Limited | 170.9 Million USD | -1783.642% |
| AlloVir, Inc. | -398 Thousand USD | 808944.221% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -3831.751% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 312037.984% |
| Aura Biosciences, Inc. | -1.29 Million USD | 248686.873% |
| Immunic, Inc. | -111 Thousand USD | 2900280.18% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -20205.286% |
| Veracyte, Inc. | 248.14 Million USD | -1197.29% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 146.061% |
| FibroGen, Inc. | 128.9 Million USD | -2397.362% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -926.295% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 570780241.844% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 27692.626% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -827457.841% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -805.936% |
| Fortrea Holdings Inc. | 424 Million USD | -659.245% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 3836.001% |
| XBiotech Inc. | -1.74 Million USD | 184687.156% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 290641.516% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 484919.277% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 7027.331% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 4361.922% |
| Agenus Inc. | 139.61 Million USD | -2205.769% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -4285.652% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -19058.484% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -727.473% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 6584.178% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -885.215% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 28528.514% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 3420.474% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -59614714.815% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 4817314.599% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1841294.672% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 860848.663% |
| Ainos, Inc. | -253.73 Thousand USD | 1268835.245% |
| Pluri Inc. | 322 Thousand USD | -999651.553% |
| Prothena Corporation plc | -129.2 Million USD | 2591.622% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -6284.269% |
| Rallybio Corporation | -150 Thousand USD | 2146233.333% |
| Kodiak Sciences Inc. | -25.94 Million USD | 12506.829% |
| Cue Biopharma, Inc. | -32.6 Million USD | 9972.727% |
| MeiraGTx Holdings plc | 287 Thousand USD | -1121572.474% |
| Annexon, Inc. | -3.26 Million USD | 98636.884% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 7813.06% |
| Moderna, Inc. | 2.15 Billion USD | -49.383% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 21322.23% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -5060.463% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1260.701% |
| Immix Biopharma, Inc. | -5468.00 USD | 58873545.501% |
| CalciMedica, Inc. | -58 Thousand USD | 5550444.828% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 51838.991% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 113292.686% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -2992.441% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 10529.937% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 275245.299% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -115882.757% |
| Nutriband Inc. | 862.1 Thousand USD | -373311.591% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 944146.921% |
| Vor Biopharma Inc. | -3.49 Million USD | 92287.858% |
| Roivant Sciences Ltd. | 109.23 Million USD | -2847.041% |
| Alkermes plc | 1.37 Billion USD | -134.178% |
| ProKidney Corp. | -3.16 Million USD | 101684.096% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 7431.026% |
| Arcellx, Inc. | 108.27 Million USD | -2873.06% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -46847.645% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 4191.978% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 9755251.515% |
| Atai Life Sciences N.V. | -5000.00 USD | 64384100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 2641841.685% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 3353433.333% |
| MediciNova, Inc. | 979.7 Thousand USD | -328488.708% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 3917.882% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3404679.345% |
| GeoVax Labs, Inc. | -20.72 Million USD | 15636.105% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -1216.458% |
| Biomea Fusion, Inc. | -4.2 Million USD | 76729.374% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 1038551.613% |
| Geron Corporation | -123.5 Million USD | 2706.576% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 64384100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 4315.102% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 130908.614% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -1406.164% |
| Royalty Pharma plc | 1.79 Billion USD | -79.453% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 342204.145% |
| Imunon, Inc. | -720 Thousand USD | 447208.006% |
| BioAtla, Inc. | -103.73 Million USD | 3203.412% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 1425.761% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 1035212.54% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 2989.403% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 339258.047% |
| 89bio, Inc. | -273 Thousand USD | 1179294.139% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 4693.28% |
| aTyr Pharma, Inc. | -2.38 Million USD | 134907.37% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -25736.276% |
| Viridian Therapeutics, Inc. | -1 Million USD | 319465.079% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -24763076823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 80480100.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -405.455% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -287585.433% |
| Liquidia Corporation | 14.6 Million USD | -21949.315% |
| Entera Bio Ltd. | -56 Thousand USD | 5748671.429% |
| GH Research PLC | -315 Thousand USD | 1022068.254% |
| Vericel Corporation | 135.57 Million USD | -2274.462% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 5894.201% |
| Xencor, Inc. | -85.26 Million USD | 3875.745% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 1456903.197% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 496542.307% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 321622.598% |
| Vaxcyte, Inc. | -75 Million USD | 4392.267% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 2021.773% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -1710.126% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1653247.577% |
| Portage Biotech Inc. | -54 Thousand USD | 5961581.481% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3404679.345% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 853999.204% |
| OncoCyte Corporation | 413 Thousand USD | -779367.312% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 71617452.614% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 1450090190.09% |
| Purple Biotech Ltd. | -196 Thousand USD | 1642548.98% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 845034.383% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 14741.379% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -4625.362% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -35796.521% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 2534903.15% |
| United Therapeutics Corporation | 2.07 Billion USD | -55.517% |
| HilleVax, Inc. | -2.15 Million USD | 149413.544% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -4858043.185% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 81763.136% |
| Pharming Group N.V. | 220.1 Million USD | -1362.581% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 21455711.837% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 482016.168% |
| Pyxis Oncology, Inc. | -2 Million USD | 161060.0% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 42887541.781% |
| Savara Inc. | -44.26 Million USD | 7373.056% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 3925953.659% |
| Curis, Inc. | 9.81 Million USD | -32712.15% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 2579835.231% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 1412029.825% |
| BeiGene, Ltd. | 2.07 Billion USD | -54.854% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -5578.803% |
| Erasca, Inc. | -3.73 Million USD | 86359.378% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 11408420.93% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 11408420.93% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 351925.137% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -40109.843% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 600697.015% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 2996.84% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 89821.293% |
| Adicet Bio, Inc. | -6.09 Million USD | 52891.079% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -789.208% |
| Aditxt, Inc. | -111.66 Thousand USD | 2883137.793% |
| Adagene Inc. | 18.11 Million USD | -17674.351% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -659572.131% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1939.585% |
| Compugen Ltd. | 31.45 Million USD | -10134.303% |
| Generation Bio Co. | -73.91 Million USD | 4455.509% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 736759.039% |
| Invivyd, Inc. | -2.02 Million USD | 158837.673% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 1170.067% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 3112302.479% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -3240.528% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -3175.273% |
| Instil Bio, Inc. | -4.75 Million USD | 67787.132% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -13252.588% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -283634.95% |
| GeoVax Labs, Inc. | -20.72 Million USD | 15636.105% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1656782.929% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 385171.77% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -3759.258% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -4403007.561% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -5955.453% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1958.789% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 912054.674% |
| Cingulate Inc. | -582.91 Thousand USD | 552356.063% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 10384616.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 16441.946% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 325929.96% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 5713777.186% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 6098.584% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 1102565.753% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 610953.89% |
| ImmunityBio, Inc. | -17.89 Million USD | 18094.41% |
| Korro Bio, Inc. | -3.63 Million USD | 88783.196% |
| Kineta, Inc. | 5.43 Million USD | -59152.715% |
| BioVie Inc. | -229.37 Thousand USD | 1403553.703% |
| Codexis, Inc. | 57.33 Million USD | -5514.818% |
| Celularity Inc. | 6.75 Million USD | -47556.551% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 2705310.084% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -80119.287% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -6363212.908% |
| Cibus, Inc. | 1.42 Million USD | -226285.373% |
| IN8bio, Inc. | -2.5 Million USD | 128816.513% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 157595.108% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -502900.0% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -313.506% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1761.293% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 8254458.974% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 169531.579% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 10045.318% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -3964.441% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 15319.365% |
| Moolec Science SA | -143.3 Thousand USD | 2246497.544% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 7707.165% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -97837.329% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 4692.952% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 170428.042% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 89125238.427% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -1391138.207% |
| Humacyte, Inc. | -76.55 Million USD | 4305.356% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 256201.83% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 379722.642% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 2617335.772% |
| Notable Labs, Ltd. | 113 Thousand USD | -2848749.558% |
| Immunovant, Inc. | -231 Thousand USD | 1393693.074% |
| Quantum-Si incorporated | 488 Thousand USD | -659572.131% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 10730766.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -172789.366% |
| Acasti Pharma Inc. | -11 Thousand USD | 29265554.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1573380.812% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 164512.666% |
| PepGen Inc. | -1.18 Million USD | 271991.892% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 14159.484% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 3898238.842% |
| Immuneering Corporation | -764.13 Thousand USD | 421385.161% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 806917.043% |
| XOMA Corporation | 3.86 Million USD | -83277.363% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 16167.079% |
| Bionomics Limited | -434.44 Thousand USD | 741084.557% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 299839.292% |
| uniQure N.V. | 2.21 Million USD | -145236.343% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 3596.508% |
| Forte Biosciences, Inc. | -9000.00 USD | 35768988.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 385632.934% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 736759.039% |
| Altimmune, Inc. | -65.37 Million USD | 5024.357% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 133843.249% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 299839.292% |
| Peak Bio, Inc. | 367.76 Thousand USD | -875232.07% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -13031.016% |
| Benitec Biopharma Inc. | 108 Thousand USD | -2980640.741% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 4127279.487% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 267697.672% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 176784.962% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 267697.672% |
| argenx SE | 1.1 Billion USD | -190.415% |
| Immunome, Inc. | -8.9 Million USD | 36242.36% |
| Verona Pharma plc | -679.62 Thousand USD | 473773.678% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1839642.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 135076.939% |
| CervoMed Inc. | -1.29 Million USD | 248950.712% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 67489.575% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -130179.239% |
| Moolec Science SA | -143.3 Thousand USD | 2246497.544% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 789061.596% |
| Design Therapeutics, Inc. | -537 Thousand USD | 599578.585% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 754011.007% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -149909.32% |
| Achilles Therapeutics plc | -4.73 Million USD | 68140.971% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 7167.709% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -7486411.628% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 391730.17% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 24465824.274% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 9755251.515% |
| Beam Therapeutics Inc. | -59.67 Million USD | 5494.825% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -2210.403% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -14841.75% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 1084005.724% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 80039.668% |
| NeurAxis, Inc. | 2.15 Million USD | -149164.804% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 33752.519% |
| Lumos Pharma, Inc. | 2 Million USD | -160298.605% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -10068.436% |
| Palisade Bio, Inc. | 246 Thousand USD | -1308517.886% |
| Nutriband Inc. | 862.1 Thousand USD | -373311.591% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -22763.636% |
| Neurogene Inc. | -3.26 Million USD | 98787.922% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 5853190.909% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 87293.933% |
| Athira Pharma, Inc. | -969 Thousand USD | 332318.782% |
| HCW Biologics Inc. | -574.82 Thousand USD | 560132.288% |
| XOMA Corporation | 3.86 Million USD | -83277.363% |
| Nektar Therapeutics | 53.47 Million USD | -5919.672% |
| Arvinas, Inc. | 71.8 Million USD | -4383.565% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 3957.13% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 5228.156% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 999851.553% |
| Rezolute, Inc. | -36 Thousand USD | 8942322.222% |
| Clene Inc. | 533 Thousand USD | -603877.486% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 250716610.903% |
| BeyondSpring Inc. | 1.75 Million USD | -183749.229% |
| Synlogic, Inc. | -1.92 Million USD | 167418.087% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 8700640.541% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 50940.177% |
| Peak Bio, Inc. | 367.76 Thousand USD | -875232.07% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 17076.217% |
| Krystal Biotech, Inc. | 47.6 Million USD | -6662.315% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -2181.648% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -63963.682% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 124430.928% |
| MannKind Corporation | 136.19 Million USD | -2263.739% |
| Ikena Oncology, Inc. | -50.49 Million USD | 6475.663% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -2858.443% |
| Gossamer Bio, Inc. | -4.38 Million USD | 73513.911% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 1277560.317% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 64384100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -2184.271% |
| Mural Oncology plc | -2.56 Million USD | 125507.09% |
| Disc Medicine, Inc. | -100 Thousand USD | 3219300.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -15411.227% |
| REGENXBIO Inc. | 53.02 Million USD | -5970.641% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 60193.863% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1673498.311% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 185966.051% |
| Vaxart, Inc. | -60.76 Million USD | 5397.961% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 1225155.179% |
| Cellectis S.A. | 18 Thousand USD | -17884344.444% |
| Longeveron Inc. | 221 Thousand USD | -1456551.584% |
| Repare Therapeutics Inc. | -80.07 Million USD | 4120.482% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -194.531% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 248878.98% |
| Revolution Medicines, Inc. | -399.66 Million USD | 905.477% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 9197814.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -6569695.918% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 62.598% |
| Denali Therapeutics Inc. | -93.34 Million USD | 3548.712% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 12851710.843% |
| Veru Inc. | 7.56 Million USD | -42448.647% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 2132020.53% |
| Cingulate Inc. | -582.91 Thousand USD | 552356.063% |
| Passage Bio, Inc. | -3.72 Million USD | 86614.378% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 26728761.574% |
| Exicure, Inc. | -1.42 Million USD | 226326.283% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 840622.193% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -118997.299% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 628022.173% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 2151870.973% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 5537.287% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -823224.808% |
| OmniAb, Inc. | 14.66 Million USD | -21848.592% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -16001.636% |
| Lipocine Inc. | -2.85 Million USD | 113021.975% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 174771.731% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 56527.695% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 213817.004% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -4174.258% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 4952715.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -3718.924% |
| Ocugen, Inc. | -33.53 Million USD | 9698.95% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 101908.982% |
| Q32 Bio Inc. | 578 Thousand USD | -556855.017% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 1214892.453% |
| Alumis Inc. Common Stock | -1.28 Million USD | 250816.511% |
| Equillium, Inc. | 35.95 Million USD | -8852.667% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 188688.166% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -642866.851% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 77871411.079% |
| Dominari Holdings Inc. | 2.03 Million USD | -157781.314% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1754709.72% |
| vTv Therapeutics Inc. | -13.59 Million USD | 23779.294% |
| Bio-Techne Corporation | 773.07 Million USD | -316.416% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -18487.678% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -598.632% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 275480.667% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 13524.52% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -27421.587% |
| Nkarta, Inc. | -5.86 Million USD | 54950.912% |
| BioCardia, Inc. | -7.24 Million USD | 44508.884% |
| Iterum Therapeutics plc | -1.75 Million USD | 184054.286% |